- Global Pharma News & Resources

Retinal Disorder Treatment Market is projected to accelerate at a CAGR of 7.7% from 2023 to 2032 | insightSLICE

The market for treating Retinal Disorder Treatment was valued at US$ 10.2 billion in 2021 and is projected to increase at a CAGR of 7.7% through 2032.

Significant financial initiatives by regulatory agencies to support ocular condition research have significantly influenced the global market. Additionally, an increase in retinal illnesses and the demand for cost-effective treatment options are expected to have a beneficial impact on market growth.

Access the sample report:

The key players of the Global Retinal Disorder Treatment Market are:

Some of the prominent companies present in the global retinal disorder treatment market include Bausch & Lomb, Inc., Acucela Inc. (Kubota Pharmaceutical Holdings Co., Ltd.), Shire (Takeda Pharmaceutical Company Limited), F. Hoffmann-La Roche Ltd., Allergan plc, Bayer AG, Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Pfizer, Inc., Novartis AG, and Graybug Vision, Inc and have been extensively covered in this report.

Current situation and future growth of the Retinal Disorder Treatment Market:

Data from the National Eye Institute estimates that by 2030 and 2050, respectively, approximately 10 and 14 million Americans would have diabetic retinopathy. By 2040, the number of people with early and advanced AMD in Europe is predicted to be between 14.9 million and 21.5 million and 3.9 to 4.8 million, respectively, according to NCBI.

Additionally, one of the main factors propelling the expansion of the global market is the growing elderly population. According to the World Population Prospects: 2019 Edition, 1 in 4 Europeans and 1 in 11 Americans will be above the age of 65 by the year 2050. Additionally, businesses are concentrating on product advancements, which are anticipated to have a beneficial impact on the market expansion.

Proceed to purchase:

Our customizable market report will provide relevant insights regarding sales, products and strategies of the major players:

The study on the global market for treatment for retinal disorders examines the industry’s competitive environment and offers company profiles and market forecasts for the top players. Additionally, the study will include information on important advancements, global and regional sales networks, business strategies, research and development initiatives, and key executives for all significant market participants.

The essential competitive data, such as strategic plans, product lines, key developments, and SWOT analysis of every company active in the retinal disorder treatment market are also taken into account in the report. This study will take into account the contributors to the retinal disorders treatment market as well as those involved in the distribution and supply chain infrastructure. The chapter on product portfolio concentrates on all of the products that these companies sell as part of their retinal treatment offerings. The recent developments section on other hand will concentrate on the most recent advancements in the global retinal disorder treatment market, such as significant partnerships and alliances, mergers and acquisition, licensing agreements, and geographic growth plans of major players.

Global Retinal Disorder Treatment Market Key Segments:

By Type

  • Diabetic Retinopathy
  • Macular Degeneration
    • Wet Macular Degeneration
    • Dry Macular Degeneration
  • Others

By Dosage Form

  • Ointments
  • Gels
  • Eye Drops
  • Capsules & Tablets
  • Eye Solutions

By Distribution Channel

  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy

By End-User

  • Hospitals
  • Pharmacies
  • Research Centers

By Geography 

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Belgium
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

Read more about the report inclusions:

Regional performance of Retinal Disorder Treatment Market

The global market for the treatment of retinal disorders is divided into five regions based on geography: North America, Europe, Asia Pacific, Middle East & Africa, and South America. This report is further divided into several sections based on smaller regions and countries. North America is expected to dominate the worldwide market in terms of geographic distribution during the projection. This is mostly because established companies like Bausch & Lomb, Inc., Novartis AG, and Allergan PLC are present in the region. Additionally, an increase in retinal diseases among American citizens is probably going to have a significant impact on the regional retinal disorder treatment economy. According to a study by WebMD, AMD affects more than 25% of Americans between the ages of 65 and 74. The global market is anticipated to benefit from these potential possibilities and increase the market share of North America.

Related reports:

Global Insulin Patch Pumps Market :

Global Neurological Biomarkers Market :

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at

Contact us:

Alex R

+1 707 736 6633

Linkedin | Twitter

Editor Details

Last Updated: 13-Dec-2022